Penn Medicine study illuminates how seniors cope with Alzheimer’s-risk biomarker results PHILADELPHIA–Testing drugs to prevent or delay the onset of Alzheimer’s dementia and using them in the clinic will mean identifying and informing adults who have a higher risk of Alzheimer’s but are still cognitively normal. A new study from the Perelman School of Medicine...